LTR Pharma Limited (ASX:LTP) Advances Multi-Market Strategy with FDA Milestone and Roxus Launch
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
4DMedical Limited (ASX:4DX) announces $6.5m annual cost reductions, supporting ongoing growth and key milestones.
Orthocell Limited (ASX:OCC) achieves first sales of its Striate+ product in the DACH region, marking a significant expansion in its European markets.
MetalsTech Limited (ASX:MTC) raises $3.3 million through strategic investments to advance the Sturec Gold Project Pre-Feasibility Study.
Vulcan Energy (ASX:VUL) is recognised as an EU Strategic Project under the Critical Raw Materials Act, advancing sustainable lithium supply in Europe.
FleetPartners Group (ASX:FPR) reaches $30 million share buy-back target and completes its Accelerate business transformation, enhancing future profitability.
African Gold Ltd (ASX:A1G) partners with Montage Gold in a A$9.17M investment to boost exploration in Côte d’Ivoire.
Altech Batteries Limited (ASX:ATC) secures €2.5M funding through Bearer Bonds to support ongoing battery projects, pending shareholder approval.
Cazaly Resources (ASX:CAZ) initiates earn-in joint venture with Brightstar to acquire up to 80% stake in Goongarrie Gold Project, advancing exploration efforts.
Brightstar Resources (ASX:BTR) and Cazaly enter a joint venture, enabling Brightstar to earn up to 80% in the Goongarrie Gold Project.